Internet Content & Information
Compare Stocks
5 / 10Stock Comparison
UPXI vs NXRT vs BYFC vs HIMS vs OLPX
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Residential
Banks - Regional
Medical - Equipment & Services
Specialty Retail
UPXI vs NXRT vs BYFC vs HIMS vs OLPX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Internet Content & Information | REIT - Residential | Banks - Regional | Medical - Equipment & Services | Specialty Retail |
| Market Cap | $11M | $756M | $92M | $6.63B | $1.36B |
| Revenue (TTM) | $25M | $252M | $63M | $2.35B | $423M |
| Net Income (TTM) | $-123M | $-32M | $-25M | $128M | $-9M |
| Gross Margin | 80.7% | 91.1% | 51.9% | 69.7% | 69.4% |
| Operating Margin | -470.1% | 11.5% | -38.8% | 4.6% | 1.6% |
| Forward P/E | — | — | — | 51.5x | 24.3x |
| Total Debt | $28M | $1.56B | $153M | $1.12B | $352M |
| Cash & Equiv. | $3M | $14M | $11M | $229M | $319M |
UPXI vs NXRT vs BYFC vs HIMS vs OLPX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Sep 21 | May 26 | Return |
|---|---|---|---|
| Upexi, Inc. (UPXI) | 100 | 1.3 | -98.7% |
| NexPoint Residentia… (NXRT) | 100 | 48.2 | -51.8% |
| Broadway Financial … (BYFC) | 100 | 37.0 | -63.0% |
| Hims & Hers Health,… (HIMS) | 100 | 340.4 | +240.4% |
| Olaplex Holdings, I… (OLPX) | 100 | 8.3 | -91.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: UPXI vs NXRT vs BYFC vs HIMS vs OLPX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, UPXI doesn't own a clear edge in any measured category.
NXRT ranks third and is worth considering specifically for income & stability and long-term compounding.
- Dividend streak 12 yrs, beta 0.62, yield 7.1%
- 211.1% 10Y total return vs HIMS's 161.9%
- Beta 0.62, yield 7.1%, current ratio 0.48x
- 7.1% yield, 12-year raise streak, vs BYFC's 3.5%, (3 stocks pay no dividend)
BYFC is the clearest fit if your priority is stability.
- Beta 0.02 vs UPXI's 3.63
HIMS carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 59.0%, EPS growth -3.8%, 3Y rev CAGR 64.5%
- 59.0% revenue growth vs UPXI's -39.2%
- 5.5% margin vs UPXI's -496.9%
- 6.0% ROA vs UPXI's -45.3%, ROIC 10.7% vs -14.0%
OLPX is the #2 pick in this set and the best alternative if sleep-well-at-night is your priority.
- Lower volatility, beta 0.84, Low D/E 40.1%, current ratio 4.58x
- Lower P/E (24.3x vs 51.5x)
- +53.4% vs UPXI's -88.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 59.0% revenue growth vs UPXI's -39.2% | |
| Value | Lower P/E (24.3x vs 51.5x) | |
| Quality / Margins | 5.5% margin vs UPXI's -496.9% | |
| Stability / Safety | Beta 0.02 vs UPXI's 3.63 | |
| Dividends | 7.1% yield, 12-year raise streak, vs BYFC's 3.5%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +53.4% vs UPXI's -88.3% | |
| Efficiency (ROA) | 6.0% ROA vs UPXI's -45.3%, ROIC 10.7% vs -14.0% |
UPXI vs NXRT vs BYFC vs HIMS vs OLPX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
UPXI vs NXRT vs BYFC vs HIMS vs OLPX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NXRT leads in 2 of 6 categories
HIMS leads 1 • UPXI leads 0 • BYFC leads 0 • OLPX leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NXRT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HIMS is the larger business by revenue, generating $2.3B annually — 94.9x UPXI's $25M. HIMS is the more profitable business, keeping 5.5% of every revenue dollar as net income compared to UPXI's -5.0%. On growth, UPXI holds the edge at +101.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $25M | $252M | $63M | $2.3B | $423M |
| EBITDAEarnings before interest/tax | -$116M | $125M | -$24M | $164M | $87M |
| Net IncomeAfter-tax profit | -$123M | -$32M | -$25M | $128M | -$9M |
| Free Cash FlowCash after capex | -$18M | $79M | -$13,000 | $73M | $24M |
| Gross MarginGross profit ÷ Revenue | +80.7% | +91.1% | +51.9% | +69.7% | +69.4% |
| Operating MarginEBIT ÷ Revenue | -4.7% | +11.5% | -38.8% | +4.6% | +1.6% |
| Net MarginNet income ÷ Revenue | -5.0% | -12.7% | -39.3% | +5.5% | -2.2% |
| FCF MarginFCF ÷ Revenue | -71.7% | +31.2% | -0.0% | +3.1% | +5.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +101.0% | +0.5% | — | +28.4% | +4.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -137.1% | 0.0% | -46.8% | -27.3% | -57.1% |
Valuation Metrics
Evenly matched — UPXI and NXRT and OLPX each lead in 2 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, NXRT's 18.6x EV/EBITDA is more attractive than OLPX's 201.2x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $11M | $756M | $92M | $6.6B | $1.4B |
| Enterprise ValueMkt cap + debt − cash | $35M | $2.3B | $234M | $7.5B | $1.4B |
| Trailing P/EPrice ÷ TTM EPS | -0.77x | -23.65x | -3.05x | 50.32x | -204.00x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 51.51x | 24.29x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 18.60x | — | 42.68x | 201.19x |
| Price / SalesMarket cap ÷ Revenue | 0.67x | 3.01x | 1.45x | 2.82x | 3.23x |
| Price / BookPrice ÷ Book value/share | 0.12x | 2.52x | 0.32x | 12.25x | 1.55x |
| Price / FCFMarket cap ÷ FCF | — | 9.05x | — | 89.61x | 23.27x |
Profitability & Efficiency
Evenly matched — UPXI and HIMS each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
HIMS delivers a 23.7% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $-3 for UPXI. UPXI carries lower financial leverage with a 0.31x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), UPXI scores 5/9 vs HIMS's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.5% | -10.1% | -9.1% | +23.7% | -1.1% |
| ROA (TTM)Return on assets | -45.3% | -1.7% | -1.9% | +6.0% | -0.6% |
| ROICReturn on invested capital | -14.0% | +1.1% | -3.7% | +10.7% | +0.6% |
| ROCEReturn on capital employed | -24.5% | +1.5% | -5.6% | +10.9% | +0.4% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 | 5 | 4 | 5 |
| Debt / EquityFinancial leverage | 0.31x | 5.18x | 0.58x | 2.07x | 0.40x |
| Net DebtTotal debt minus cash | $25M | $1.5B | $142M | $892M | $34M |
| Cash & Equiv.Liquid assets | $3M | $14M | $11M | $229M | $319M |
| Total DebtShort + long-term debt | $28M | $1.6B | $153M | $1.1B | $352M |
| Interest CoverageEBIT ÷ Interest expense | -10.65x | 0.47x | -0.87x | — | 0.83x |
Total Returns (Dividends Reinvested)
HIMS leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HIMS five years ago would be worth $23,764 today (with dividends reinvested), compared to $120 for UPXI. Over the past 12 months, OLPX leads with a +53.4% total return vs UPXI's -88.3%. The 3-year compound annual growth rate (CAGR) favors HIMS at 29.4% vs UPXI's -74.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -29.8% | +2.6% | +29.3% | -23.2% | +51.1% |
| 1-Year ReturnPast 12 months | -88.3% | -15.2% | +52.8% | -51.0% | +53.4% |
| 3-Year ReturnCumulative with dividends | -98.4% | -15.5% | +30.9% | +116.6% | -48.6% |
| 5-Year ReturnCumulative with dividends | -98.8% | -23.0% | -33.2% | +137.6% | -91.7% |
| 10-Year ReturnCumulative with dividends | -98.8% | +211.1% | -37.6% | +161.9% | -91.7% |
| CAGR (3Y)Annualised 3-year return | -74.8% | -5.5% | +9.4% | +29.4% | -19.9% |
Risk & Volatility
Evenly matched — BYFC and OLPX each lead in 1 of 2 comparable metrics.
Risk & Volatility
BYFC is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than UPXI's 3.63 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. OLPX currently trades 100.0% from its 52-week high vs UPXI's 8.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 3.63x | 0.62x | 0.02x | 2.40x | 0.84x |
| 52-Week HighHighest price in past year | $15.50 | $38.30 | $9.86 | $70.43 | $2.04 |
| 52-Week LowLowest price in past year | $0.54 | $23.79 | $5.60 | $13.74 | $0.99 |
| % of 52W HighCurrent price vs 52-week peak | +8.6% | +77.8% | +99.8% | +36.4% | +100.0% |
| RSI (14)Momentum oscillator 0–100 | 59.1 | 71.0 | 75.4 | 54.5 | 68.5 |
| Avg Volume (50D)Average daily shares traded | 5.0M | 216K | 4K | 34.9M | 5.5M |
Analyst Outlook
NXRT leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: NXRT as "Hold", HIMS as "Hold", OLPX as "Hold". Consensus price targets imply 15.6% upside for HIMS (target: $30) vs -9.4% for NXRT (target: $27). For income investors, NXRT offers the higher dividend yield at 7.07% vs BYFC's 3.54%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | — | Hold | Hold |
| Price TargetConsensus 12-month target | — | $27.00 | — | $29.67 | $1.91 |
| # AnalystsCovering analysts | — | 10 | — | 19 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | +7.1% | +3.5% | — | — |
| Dividend StreakConsecutive years of raises | — | 12 | 2 | — | 2 |
| Dividend / ShareAnnual DPS | — | $2.11 | $0.35 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.0% | 0.0% | +1.4% | 0.0% |
NXRT leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). HIMS leads in 1 (Total Returns). 3 tied.
UPXI vs NXRT vs BYFC vs HIMS vs OLPX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is UPXI or NXRT or BYFC or HIMS or OLPX a better buy right now?
For growth investors, Hims & Hers Health, Inc.
(HIMS) is the stronger pick with 59. 0% revenue growth year-over-year, versus -39. 2% for Upexi, Inc. (UPXI). Hims & Hers Health, Inc. (HIMS) offers the better valuation at 50. 3x trailing P/E (51. 5x forward), making it the more compelling value choice. Analysts rate NexPoint Residential Trust, Inc. (NXRT) a "Hold" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — UPXI or NXRT or BYFC or HIMS or OLPX?
On forward P/E, Olaplex Holdings, Inc.
is actually cheaper at 24. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — UPXI or NXRT or BYFC or HIMS or OLPX?
Over the past 5 years, Hims & Hers Health, Inc.
(HIMS) delivered a total return of +137. 6%, compared to -98. 8% for Upexi, Inc. (UPXI). Over 10 years, the gap is even starker: NXRT returned +211. 1% versus UPXI's -98. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — UPXI or NXRT or BYFC or HIMS or OLPX?
By beta (market sensitivity over 5 years), Broadway Financial Corporation (BYFC) is the lower-risk stock at 0.
02β versus Upexi, Inc. 's 3. 63β — meaning UPXI is approximately 14484% more volatile than BYFC relative to the S&P 500. On balance sheet safety, Upexi, Inc. (UPXI) carries a lower debt/equity ratio of 31% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — UPXI or NXRT or BYFC or HIMS or OLPX?
By revenue growth (latest reported year), Hims & Hers Health, Inc.
(HIMS) is pulling ahead at 59. 0% versus -39. 2% for Upexi, Inc. (UPXI). On earnings-per-share growth, the picture is similar: Upexi, Inc. grew EPS 92. 8% year-over-year, compared to -81. 8% for Broadway Financial Corporation. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — UPXI or NXRT or BYFC or HIMS or OLPX?
Hims & Hers Health, Inc.
(HIMS) is the more profitable company, earning 5. 5% net margin versus -86. 5% for Upexi, Inc. — meaning it keeps 5. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NXRT leads at 11. 1% versus -79. 1% for UPXI. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is UPXI or NXRT or BYFC or HIMS or OLPX more undervalued right now?
On forward earnings alone, Olaplex Holdings, Inc.
(OLPX) trades at 24. 3x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 27. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HIMS: 15. 6% to $29. 67.
08Which pays a better dividend — UPXI or NXRT or BYFC or HIMS or OLPX?
In this comparison, NXRT (7.
1% yield), BYFC (3. 5% yield) pay a dividend. UPXI, HIMS, OLPX do not pay a meaningful dividend and should not be held primarily for income.
09Is UPXI or NXRT or BYFC or HIMS or OLPX better for a retirement portfolio?
For long-horizon retirement investors, Broadway Financial Corporation (BYFC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
02), 3. 5% yield). Upexi, Inc. (UPXI) carries a higher beta of 3. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BYFC: -37. 6%, UPXI: -98. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between UPXI and NXRT and BYFC and HIMS and OLPX?
These companies operate in different sectors (UPXI (Communication Services) and NXRT (Real Estate) and BYFC (Financial Services) and HIMS (Healthcare) and OLPX (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: UPXI is a small-cap quality compounder stock; NXRT is a small-cap income-oriented stock; BYFC is a small-cap income-oriented stock; HIMS is a small-cap high-growth stock; OLPX is a small-cap quality compounder stock. NXRT, BYFC pay a dividend while UPXI, HIMS, OLPX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 50%
- Gross Margin > 48%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.